key: cord-0955682-9081lbte authors: Majnooni, Mohammad Bagher; Fakhri, Sajad; Shokoohinia, Yalda; Kiyani, Narges; Stage, Katrina; Mohammadi, Pantea; Gravandi, Mohammad Mehdi; Farzaei, Mohammad Hosein; Echeverría, Javier title: Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury date: 2020-11-18 journal: Front Pharmacol DOI: 10.3389/fphar.2020.588467 sha: 57fd4aff173a697d4c27cd49e51f1c510588f8f6 doc_id: 955682 cord_uid: 9081lbte Since the outbreak of coronavirus disease 2019 (COVID-19) in December 2019, millions of people have been infected and died worldwide. However, no drug has been approved for the treatment of this disease and its complications, which urges the need for finding novel therapeutic agents to combat. Among the complications due to COVID-19, lung injury has attained special attention. Besides, phytochemicals have shown prominent anti-inflammatory effects and thus possess significant effects in reducing lung injury caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Also, the prevailing evidence reveales the antiviral effects of those phytochemicals, including anti-SARS-CoV activity, which could pave the road in providing suitable lead compounds in the treatment of COVID-19. In the present study, candidate phytochemicals and related mechanisms of action have been shown in the treatment/protection of lung injuries induced by various methods. In terms of pharmacological mechanism, phytochemicals have shown potential inhibitory effects on inflammatory and oxidative pathways/mediators, involved in the pathogenesis of lung injury during COVID-19 infection. Also, a brief overview of phytochemicals with anti-SARS-CoV-2 compounds has been presented. The complex pathophysiological mechanisms behind viral diseases, along with the associated side effects of the present conventional drugs, urge the need for introducing alternative treatments. Among viral infections, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and the newest human CoVs (HCoVs) associated with the outbreak of coronavirus disease 2019-SARS-CoV-2 (COVID-19) have caused acute respiratory distress syndrome . Based on the pathological findings, the inflammatory cytokines/signaling pathways lead to pulmonary edema and, ultimately, lung injury in COVID-19 patients (Merad and Martin, 2020) . Considering their potential effects in targeting several dysregulated mediators, phytochemicals could be auspicious agents in the treatment/ management of various diseases (Mani et al., 2020) . The medicinal plants and phytochemicals target multiple proinflammatory and oxidative mediators such as tumor necrosis factor-α (TNF-α), interleukin-(IL-) 1β, IL-6, IL-8, matrix metalloproteinases (MMPs), nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and reactive oxygen species (ROS) . Therefore, owing to the involvement of inflammation and oxidative stress in the pathogenesis of lung injury, phytochemicals have attracted particular attention to providing novel agents in combating coronaviruses and related complications (Bellik et al., 2012; Cornélio Favarin et al., 2013b) . This article presents an overview of phytochemicals, including alkaloids, coumarins, polyphenols, especially flavonoids, quinones, and terpenes to show noticeable effects against lung injury. Therefore, they could be introduced as ameliorative agents against SARS-CoV-2-induced lung injury. Moreover, based on their simultaneous antiviral and preventive effects against lung injury, some phytochemicals such as matrine, cepharanthine, osthole, wogonin, myricetin, and triptolide have been also provided as promising candidates in the management of COVID-19. In general, this review article aims to introduce phytochemicals as potential therapeutic agents against coronavirus complications, focusing on lung injury. In striking contrast to the history of HCoVs, as relatively harmless respiratory pathogens, the outbreak of SARS and the emergence of MERS pose the CoVs as important pathogens in respiratory tract infections. SARS-CoV, MERS-CoV, and SARS-CoV-2 can cause clinical complications leading to severe diseases presented as acute respiratory distress syndrome (ARDS) (Yin and Wunderink, 2018) . HCoVs contain single-stranded, polycistronic RNA genomes of positive polarity (∼30 kb). These viral genomes are translated into multiple nonstructural proteins (ORF1a and ORF1b), structural proteins (S, E, M, and N) , and lineage-specific accessory proteins showing differences in these viruses. For instance, in the case of SARS-CoV, accessory proteins include ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8a, ORF8b, and ORF9b (Fung et al., 2020) . The most common clinical symptoms in SARS-CoV-2 include fever, cough, dyspnea, fatigue, headache, myalgia, and diarrhea. Some patients afterward suffer from shortness of breath and recurrent or ongoing fever. In nearly 13% of patients, intense care treatment (e.g., mechanical ventilation) should be applied Wang D. et al., 2020) . The pathobiology of SARS-CoV-2 and related molecular mechanisms behind the coronavirus-associated lung injury are not yet completely understood; however, the role of some key molecular intermediates are not deniable (Marini and Gattinoni, 2020) . Among those signaling mediators, TNF-α, IL-1, IL-6, IL-8, and IL-1β, NF-κB, MMPs, MAPK, and COX-2 seem to play critical roles in the pathogenesis of COVID-19 and associated lung injury (Fakhri et al., 2020b; Merad and Martin, 2020) . In terms of ROS, iNOS, as well as nuclear factor erythroid 2-like 2 (Nrf2), autophagy-related molecules (LC-3II, Atg5, and Beclin1), and Janus kinase-signal transducers and activator of transcription (JAK/STATs) pathway have shown an important role (Seif et al., 2017) . From the other point of view, the extracellular signal-regulated kinase (ERK) and protein kinase B (Akt) signaling pathways are of the other dysregulated mediators following lung injury (Mo et al., 2014; Tsai et al., 2015; Jin et al., 2018) . In COVID-19 patients, angiotensin-converting enzyme 2 (ACE2) receptor, located on alveolar epithelial cells, has attracted growing attention, as a high-affinity receptor and cotransporter for SARS-CoV-2 entrance to the lung (South et al., 2020; Ziai et al., 2020) . Dysregulation of ACE2/Ag (1-7)/Mas receptor and ACE1/Ag II/Ag II type 1 receptor pathways could enhance ACE2, thereby increasing the chances of the viral entry (Rico-Mesa et al., 2020; South et al., 2020) . Besides, the dysregulation of ACE2 by SAR-CoV-2 infection inhibits the degradation of Ag II into angiotensin (Ag) (1-7), exacerbates inflammation, and leads to vascular permeability, as well as cardiovascular/lung complications South et al., 2020) . Based on the pathological findings, an edematous lung with increased weight was also observed in this disease (Ding et al., 2003; Nicholls et al., 2003) . Large multinucleated cells (macrophages and pneumocytes) and atypical enlarged pneumocytes comprise large nuclei, prominent nucleoli, and amphophilic granular cytoplasm, which have often been observed in the lungs of SARS patients. However, none of these signs can be considered as a unique feature of SARS-related pathology. The other pathological features usually observed in SARS include squamous metaplasia of bronchial and alveolar epithelial cells; cilia loss of bronchiolar epithelial cells; subpleural multiplication of fibrogranulative tissue in small airways and airspaces; vascular injury hemophagocytosis in residing mononuclear cells in pulmonary tissue; and apoptosis in epithelial cells, lymphocytes, monocytes/macrophages, and pneumocytes (Gu and Korteweg, 2007) . Apart from a respiratory infection, gastrointestinal and central nervous system (CNS) infection was also reported in some patients suffering from SARS (Fung et al., 2020) . Additionally, in most SARS autopsies, both extensive necrosis of the spleen and atrophy of the white pulp were reported. Reduction of CD4 + , CD8 + , and CD20 + lymphocytes, dendritic cells, macrophages, and natural killer cells residing in the spleen, as well as atrophy and decrement of the lymph nodes lymphocytes, were often observed. The presence of SARS-CoV was also confirmed in circulating monocytes and T lymphocytes and to some degree in B lymphocytes and natural killer cells (Chong et al., 2004; Gu et al., 2005) . The liver is another organ that is affected during the course of this disease. For example, the increment of serum alanine aminotransferase level in SARS patients was associated with some adverse outcomes. Besides, hemophagocytosis or bone marrow hypoplasia, destruction of epithelial cells in the thyroid glands, myofiber necrosis and atrophy of skeletal muscle tissue, and necrosis and vacuities of the adrenal medulla can occur in some SARS patients (Gu and Korteweg, 2007) . Since the outbreak of COVID-19 happened, several researchers have focused on the use of natural compounds for the treatment of related complications. Most of those studies are in vitro and in vivo screening of phytochemicals against coronaviruses (especially SARS-CoV-2), computer docking models studies on predicting the anti-CoVs effects of these compounds against the coronavirus family members such as SARS-CoV, MERS-CoV, and SARS-CoV-2 (Mani et al., 2020; Zhang D.-h. et al., 2020) . According to those studies, natural polyphenol compounds such as quercetin (Chiow et al., 2016) , kaempferol (Schwarz et al., 2014) , myricetin (Yu et al., 2012) , apigenin (Ryu et al., 2010a) , and resveratrol (Wahedi et al., 2020) have prominent activities against coronaviruses. Cho and coworkers showed that the geranylated flavonoids (tomentin A-E) isolated from Paulownia tomentosa (Thunb.) Steud. (Paulowniaceae) inhibited the papain-like protease as a vital enzyme for SARS-CoV propagation (Cho et al., 2013) . In addition, three flavonoid compounds including apigenin-7-O-rhamnoglucoside, herbacetin, and pectolinarin at the concentration of 20 µM blocked the crucial enzyme for SARS-CoV replication, 3C-like protease (Jo et al., 2020) . Also, 3C-like protease was inhibited with ten polyphenols isolated from Broussonetia papyrifera (L.) L'Hér. ex Vent. (Moraceae), especially with papyriflavonol A at 3.7 µM (Park et al., 2017) . On the other hand, the molecular docking study on traditional Chinese medicinal compounds against SARS-CoV-2 showed that the theaflavin, as a flavonoid compound isolated from black tea, Camellia sinensis (L.) Kuntze (Theaceae), via the inhibition of the SARS-CoV-2 RNA-dependent RNA polymerase, can exert anticoronavirus activities (Lung et al., 2020) . Also, hesperidin, which is abundant in citrus, has shown a potential inhibitory effect on ACE2; thereby it could be a good candidate for clinical trials on SARS-CoV-2 (Haggag et al., 2020) . Besides, alkaloids have also shown antiviral effects against coronaviruses. Lycorine, as an indolizidine alkaloid isolated from Lycoris radiata (L'Hér.) Herb. (Amaryllidaceae), showed anti-SARS-CoV activities at 15.7 nM (Li et al., 2005) . Gyebi and coworkers introduced the 10hydroxyusambarensine, an indole alkaloid isolated from Strychnos usambarensis Gilg ex Engl. (Loganiaceae), and 6oxoisoiguesterin, a bisnorterpenes isolated from Salacia madagascariensis (Celastraceae) as the anti-SARS-CoV-2 agents, through their highest affinity in binding to 3C-like protease obtained from a docking study (Gyebi et al., 2020) . Tetrandrine (0.33 µM), fangchinoline (1.01 µM), and cepharanthine (0.83 µM), bisbenzylisoquinoline alkaloids of Stephania tetrandra S. Moore (Menispermaceae), are other phytochemicals that showed the anti-HCoV activities (Kim et al., 2019) . Sanguinarine, palmatine, berberine, chelidonine, jatrorrhizine, ipecac alkaloids, and emetine are other alkaloids that are suggested as anti-SARS-CoV-2 agents (Bleasel and Peterson, 2020; Wink, 2020) . Besides, among other anti-CoVs phytochemicals saikosaponins (A, B2, C, D) as triterpene saponin glycosides of Bupleurum spp. (Apiaceae) have shown hopeful results. The saikosaponin B 2 at 6 μM, in addition to possessing an anti-CoV effect, also showed inhibitory effects on the virus propagation stages (Cheng et al., 2006) . Glycyrrhizin is another triterpene saponin, obtained from Glycyrrhiza glabra L. (Fabaceae), with anti-CoV activity and blocking effects on several steps of viral replication such as permeation and adsorption (Bailly and Vergoten, 2020; Cinatl et al., 2003) . Triterpenoids of Euphorbia neriifolia L. (Euphorbiaceae) also indicated anti-HCoV effects. Among these triterpenoids, friedelane derivatives showed the greatest effect . The phytochemicals in essential oils are among the other anti-HCoV natural compounds (Nadjib, 2020) . Jensenone and 1,8-cineole, as monoterpenes in Eucalyptus spp. (Myrtaceae) essential oil, showed anti-CoV effects in docking studies (Sharma and Kaur, 2020a; Sharma and Kaur, 2020b) . Savinin, a lignoid isolated from Chamaecyparis obtusa (Siebold & Zucc.) Endl. (Cupressaceae), and betulinic acid, a triterpenoid of Betula spp. (Betulaceae), showed anti-SARS-CoV activities via the inhibition of 3CL protease at 25 and 10 μM, respectively (Wen et al., 2007) . Also, quinones such as emodin, aloe-emodin, and Tripteryguim regelii (Celastraceae) quinones including celastrol, pristimererin, tingenone, and iguesterin showed the anti-SARS-CoV activities. The emodin, aloe-emodin, and iguesterin inhibited the 3CL protease at 20, 366, and 2.6 µM, respectively (Lin et al., 2005; Ryu et al., 2010b; Schwarz et al., 2011) . In addition, emodin, isolated from Rheum officinale Baill. and Polygonum multiflorum (Thunb.) Moldenke (Polygonaceae), inhibited interaction between ACE2 and S protein at 200 µM. With mention to the above, it can be said that phytochemicals are potential sources for the discovery of effective drugs against coronaviruses, especially anti-SARS-CoV-2. For this purpose, several clinical trials on phytochemicals such as polyphenols (NCT04400890), hesperidin and diosmin (NCT04452799), resveratrol (NCT04542993, NCT04536090, and NCT04377789), quercetin (NCT04468139 and NCT04377789), artemisinin and curcumin (NCT04382040), epigallocatechin gallate (NCT04446065), glycyrrhizin (NCT04487964), colchicine (NCT04527562, NCT04392141, NCT04375202, NCT04355143, and NCT04360980), berberine (NCT04479202), and tetrandrine (NCT04308317) have been designed and are going on. The structures of some anti-CoV phytochemicals are shown in Figure 1 . Medicinal plants and isolated phytochemicals can cover multiple therapeutic targets at the same time and lie in the fact that they are widely used in the treatment of various diseases, including viral diseases and related complications. Since infection with any of the viruses of the Coronaviridae family, including SARS-CoV-2, can cause severe damage to the pulmonary system (Ding et al., 2003) , the plant-derived secondary metabolites can play a significant role in reducing these pulmonary complications. The phytochemicals with different molecular targets and signaling mechanisms, including reducing proinflammatory and oxidant mediators such as TNF-α, IL-1, IL-6, IL-8, IL-1β, NF-κB, MMPs, iNOS, MAPK, COX-2, and ROS, minimize lung injury. Therefore, protective effects on lung injury, along with other effects, including antiviral (especially anti-CoVs) effects, have attracted the attention of many researchers on the use of phytochemicals as potential strategies for discovering new anti-CoV agents regarding controlling related complication (Bellik et al., 2012; Cornélio Favarin et al., 2013b) . Alkaloids are one of the largest classes of natural products that are mainly found in several plant families such as Solanaceae, Ranunculaceae, Rubiaceae, Papaveraceae, Amaryllidaceae, and Fabaceae. The main feature of this group is the presence of the nitrogen atom in their structure (Yang and Stöckigt, 2010) . Several studies showed that alkaloids have the potential of reducing lung injury induced by different methods. Sinomenine ( Figure 2) is an isoquinoline alkaloid that is isolated from the stem and rhizome of Sinomenium acutum (Thunb.) Rehder & E.H.Wilson (Menispermaceae). It reduced the lung injury induced by lipopolysaccharides (LPS) and Escherichia coli, via regulation of inflammatory signaling pathway, including the downregulation of IL-6, IL-1β, TNF-α, NF-κB, iNOS, and COX-2 and upregulation of the protective antiinflammatory adenosine A2A receptor. Sinomenine also inhibited oxidative stress markers, including the increase of the superoxide dismutase (SOD) and the decrease of the malondialdehyde (MDA) . Besides, sinomenine [100 mg/kg, intraperitoneally (i.p.)] upregulated the expression of Nrf2 and autophagy-related molecules (LC-3II, Atg5, and Beclin1), as critical mediators in increasing cell resistance against oxidative stress and inflammation, 1 h after inducing lung injury by LPS (8 mg/kg) in mice. Moreover, lung wet/dry (W/D) ratio, pulmonary edema, and the protein leakage into bronchoalveolar lavage fluid (BALF), as the pathological markers of lung injury, were decreased by sinomenine . In addition, six isosteroid alkaloids (imperialine, verticinone, verticine, imperialine-3-β-Dglucoside, delavine, and peimisine) and total alkaloid extraction isolated from bulbs of Fritillaria cirrhosa D.Don (Liliaceae) showed the protective effects on lung injury, induced by LPS and cigarette smoke, increase the expression of Nrf2 and heme oxygenase (HO-1), and reduce ROS production, IL-6, and TNF-α expression in vivo and in vitro Liu S. et al., 2020) . Toll-like receptor 4 (TLR4) is an inflammatory signaling pathway whose expression is increased in acute lung injury (Yang H.-Z. et al., 2012) . Sophocarpine (25 and 50 mg/kg, i.p.), quinolizidine alkaloid isolated from the seeds of Sophora alopecuroides L. (Fabaceae), reduced LPS-induced lung injury in mice by the inhibition of TLR4 expression . Zhang et al. reported that tabersonine, as a monoterpenoid indole alkaloid isolated from the root of Catharanthus roseus (L.) G.Don (Apocynaceae), has shown a protective effect on lung injury induced by LPS in vivo (20 mg/kg, i.p.) and in vitro (mouse bone marrowderived macrophages, 10 µM). This study showed that tabersonine decreased the expression of TNF receptor-associated factor 6 (TRAF6) and thereby blocked p38MAPK-activated protein kinase 2 (MAPK/MK2) and NF-κB activities. The amelioration of the aforementioned signaling pathways/mediators leads to the inhibition of proinflammatory mediators and the reduction of pathological indices of lung injury such as total protein concentrations in BALF ameliorated lung injury . Berberine, an isoquinoline alkaloid isolated from different species such as Berberis vulgaris L. (Berberidaceae) and Coptis chinensis Franch. (Ranunculaceae), has indicated protective effects on LPS-induced lung injury via activating Nrf2 and increasing the expression of HO-1 in C57BL/6 mice at 10 mg/kg (i.p., 24 and 2 h before injection of LPS, 2.5 mg/kg), as well as the in vitro manner on the human bronchial epithelial cell line at 5 and 10 μM concentrations. Berberine also reduced the pulmonary edema and the protein leakage into BALF of mice (Liang et al., 2019) . Matrine (tetracycloquinolizindine) , antidesmone (tetrahydroquinoline) , cepharanthine (bisbenzylisoquinoline) , epigoitrin (pyrrolidine) (Luo et al., 2019) , isotetrandrine (bisbenzyltetrahydroisoquinoline) (Liang et al., 2014) , neferine (bisbenzylisoquinline) (Zhao et al., 2010) , and oxysophoridine (quinolizidine) (Fu et al., 2015) are other alkaloids that have shown anti-lung injury effects evaluated by in vivo and in vitro experiments. Accordingly, they regulated the proinflammation mediators and oxidative markers ( Table 1) . show the chemical structures and schematic diagram of the possible mechanisms of action of some alkaloids and other phytochemicals with protective effects against lung injury, respectively. Generally, the alkaloids especially quinolines and quinazolines have shown therapeutic effects on lung injury via inhibiting the MAPKs pathway and their interconnected mediators, including TLR4, and inflammatory cytokines such as IL-1β, IL-6, and TNF-α. These agents have also been shown to enhance the Nrf2/HO-1 pathway, glutathione, and SOD as antioxidative stress markers. Therefore, this impressive role on lung injury, along with the other beneficial roles of the alkaloids especially their antiviral effects, introduces these compounds as the multitarget agents for the treatment of coronavirus infection and their complications. (2001) (2011) In vivo LPS Yes Dai et al. (1997) , Leung et al. (2017) 5-LOX, 5-Lipoxygenase; Akt, protein kinase B; BALF, bronchoalveolar lavage fluid; Bcl-2/Bax, B-cell lymphoma protein 2/associated X; CAT, catalase; CO 2 , carbon dioxide; COX-2, cyclooxygenase-2; ERK, extracellular signal-regulated kinase; GPx, glutathione peroxidase; GSH, glutathione; GST, glutathione S-transferase; HMGB1, high-mobility group box 1 protein; HO-1, heme oxygenase-1; ICAM-1, intercellular adhesion molecule 1; IFITM3, interferon-induced transmembrane protein 3; IFN-b, interferon Beta 1; IL, interleukin; iNOS, inducible nitric oxide synthase; IκBα, inhibitor of nuclear factor-kappa B α; JAK/STATs, janus kinase-signal transducers and activator of transcription; JNK, jun N-terminal kinases; JNK/SAPK, JNK/stress-activated protein kinases; LDH, lactate dehydrogenase; LPS, lipopolysaccharides; MAPK, mitogen-activated protein kinase; MAPK/MK2, MAPK/activated protein kinase 2; MAVS, mitochondrial antiviral signaling; MCP-1, monocyte chemoattractant protein-1; MDA, malondialdehyde; MFN2, mitofusin-2; MIP-2, macrophage inflammatory protein 2; MMPs, matrix metalloproteinases; MPO, myeloperoxidase; MyD88, myeloid differentiation factor 88; NADPH, nicotinamide adenine dinucleotide phosphate; NF-κB, nuclear factor-κB; NLRP3, nucleotide-binding oligomerization domain-like receptors pyrin domain-containing protein 3; NR, not reported; Nrf2, nuclear factor erythroid 2-related factor two; O 2 , oxygen; PGE2, prostaglandin E2; PI3K, phosphoinositide 3-kinases; ROS, reactive oxygen species; SOD, superoxide dismutase; TGF-β1, transforming growth factor β1; TLR4, toll-like receptor 4; TNF-α, tumor necrosis factor-α; TRAF6, TNF receptor-associated factor six. Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 588467 FIGURE 3 | Selected chemical structures of alkaloids, coumarins, terpenes, quinones, and other phytochemicals with potential protective effects against lung injury. Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 588467 11 Coumarins are the heterocyclic phytochemicals with 2H-1benzopyran-2-one chemical structure. The Apiaceae is one of the greatest plant families that coumarins are isolated from its species (Ribeiro and Kaplan, 2002) . Anti-inflammatory and antioxidant properties are two prominent effects of coumarins along with other pharmacological and biological activities such as cytotoxic and anticancer, antiviral, antiangiogenic, anticoagulant, edema-protective, and anxiolytic effect (Fylaktakidou et al., 2004; Venugopala et al., 2013; Srikrishna et al., 2018) . The downregulation of inflammatory mediators, including NF-κB, TNF-α, iNOS, and MAPKs pathway, and inhibiting oxidative factors such as ROS and free radicals are critical mechanisms of coumarins. Therefore, coumarinic compounds are thought to exert anti-inflammatory effects on therapeutic applications against lung injury induced by LPS and other destructive inducers (Fylaktakidou et al., 2004; Bansal et al., 2013) . Daphnetin, as a hydroxy coumarin isolated from Daphne spp., showed protective effects on lung injury that are induced by LPS in vivo and in vitro. Daphnetin downregulated the NF-κB pathway via increasing the expression of NF-κB, and TNFα-induced protein 3, in lung tissues of the C57BL/6 mice (5 mg/kg, i.p.) and the murine peritoneal macrophages (RAW264.7, 160 μM). In another study, pretreatment of mice with 5 mg/kg i.p. of daphnetin significantly reduced protein and cytokines (TNF-α, IL-6, and IL-1β) leakage into BALF that is stimulated with LPS (1 mg/kg). Consequently, daphnetin (80 and 160 μM) suppressed the expression of IL-6 and TNF-α in adenocarcinoma human lung epithelial cell lines (A549), which is induced by LPS (100 ng/ml) . Also, the regulation of JAK/STATs pathway has a critical role in the production of proinflammatory mediators such as TNF-α, iNOS, COX-2, IL6, and IL-1β (Seif et al., 2017) . Daphnetin inhibited the LPS-induced cytokines expression through downregulating the JAK/STATs signaling in C57/BL6 mice (5 mg/kg, i.p.) and RAW264.7 cells (5, 10, and 20 μM). Daphnetin also reduced ROS production in these doses . Another study showed that the praeruptorins D and E (80 mg/kg, gavage), as pyranocoumarins found in Kitagawia praeruptora (Dunn) Pimenov (syn. Peucedanum praeruptorum) roots, similar to daphnetin inhibited NF-κB and interconnected inflammatory cytokines (IL-6 and TNF-α) in male BALB/c mice with lung injury induced by intranasal administration of LPS (40 μg/ml) and hydrochloric acid (0.1 N). The total protein level, neutrophils, and cell infiltration in BALF were also reduced at 40 and 80 mg/kg of daphnetin . IL-17 as one of the prominent inflammatory cytokines is produced by T lymphocyte helper cells whose production is FIGURE 4 | The pharmacological mechanisms and therapeutic targets of phytochemicals against coronavirus-associated lung injury. ACE, angiotensin-converting enzyme; Ag, angiotensin; Akt, protein kinase B; ARE, antioxidant response element; Anti-SARS-CoV, anti-severe acute respiratory syndrome coronavirus; Ca 2+ , calcium; CalM, calmodulin; NAFT, nuclear factor of activated T cells; CAT, catalase; COX-2, cyclooxygenase-2; ERK, extracellular signal-regulated kinase; GSH, glutathione; GST-1α, glutathione S-transferase; HO-1, heme oxygenase-1; IFNγ, interferon γ; IL, interleukin; IKK, inhibitor of nuclear factor-κB (IκB) kinase; MAPK, mitogen-activated protein kinase; MMPs, matrix metalloproteinases; NF-κB, nuclear factor-κB; Nrf2, nuclear factor erythroid 2-related factor 2; SOD, superoxide dismutase; TLR4, toll-like receptor 4; TNF-α, tumor necrosis factor-α; TNFR, TNF receptor. Frontiers in Pharmacology | www.frontiersin.org Volume 11 | Article 588467 regulated by retinoic acid-related orphan receptor gamma t (RORγt). Esculetin (20 and 40 mg/kg, i.p.) as a hydroxycoumarin is widely found in Fraxinus spp., with the potential of reducing lung injury via inhibiting the RORγt and then the suppression of IL-17 in mice. At the same doses, esculetin also inhibited MAPKs and neutrophils/macrophages entry in mice lung . Besides, the protective effects of osthole, as prenylated coumarins purified first from the fruit of Cnidium monnieri (L.) Cusson (Apiaceae), were reported in several in vivo and in vitro studies (Table 1) . Reducing the expression of cytokines (IL-1β, IL-6, and TNF-α) and blocking the NF-κB and ERK and Akt signaling pathway are of the critical protective mechanisms of osthole on lung injury (Mo et al., 2014; Tsai et al., 2015; Jin et al., 2018) . Also, Shi and coworkers proposed that inhibition of ACE2 and Ag (1-7) depletion in lung tissues are other protective mechanisms of osthole (40 mg/kg, gavage) against the lung injury induced by LPS (Shi et al., 2013) . Also, ACE2 has shown ameliorating effects on lung injury complications induced by acid, LPS, and viruses, including SARS coronavirus and influenza (Gu et al., 2016) . Isofraxidin is another hydroxycoumarin, isolated from Fraxinus spp., with prominent anti-inflammatory effects, especially pulmonary inflammations induced by influenza virus Majnooni et al., 2020) . Also, isofraxidin (5, 10, and 15 mg/kg, i.p.) showed improving effects on LPSinduced lung injury via reducing the production of inflammatory cytokines (IL-6 and TNF-α) and prostaglandin E 2 (PGE2). Consequently, it blocked the secretion of PGE2 in mice serum and BALF, also reduced COX-2 gene expression, and led to further improvement of lung damage (Niu et al., 2015) . Consistently, anomalin , fraxin , psoralidin (Yang H. J. et al., 2011) , scoparone (Niu et al., 2014) , and umbelliferone (Wang D. et al., 2019) are other coumarinic compounds which have ameliorating effects on lung injury (Table 1) . According to the prominent anti-inflammatory effects of natural coumarins, along with their other pharmacological effects, these compounds can be introduced as one of the new sources of drug discovery for the protection and treatment of lung injury. Structurally, polyphenols are divided into several categories, including flavonoids (flavonols, flavones, flavanones, flavanols, anthocyanins, and isoflavones), phenolic acids (hydroxybenzoic acid and hydroxycinnamic acids), stilbenes, catechins, tannins, and lignans (Pietta et al., 2003) provided in Figure 2 . From the mechanistic point of view, the inhibition of MAPKs cascade, phosphatidylinositol 3-kinase (PI3K)/Akt, Src family kinase-Bruton's tyrosine kinase-Vav, myeloid differentiation factor 88-TLR4, Nrf2/HO-1, and NF-κB Wang et al., 2018; de Oliveira et al., 2019; Tsai et al., 2019; Cao et al., 2020) , enzymes involved in the arachidonic acid pathway, inflammatory cytokines, and NF-κB signaling pathway are among the main targets of polyphenols in combating inflammation (Santangelo et al., 2007; Guo et al., 2009) . They have also shown to suppress the expression of macrophage inflammatory proteins 1α and 2, IL-1β, IL-6, and TNF-α as inflammatory cytokines de Oliveira et al., 2019) , decrease ROS production and iNOS expression (Cao et al., 2011; Zhu et al., 2019) , decrease SOD activity and MDA levels (Mo et al., 2014) , and increase the activity of sirtuin 1 as an antioxidant and anti-inflammatory factor , in in vitro and in vivo studies at different doses and routes of administration. Resveratrol is a stilbenoid widely found in Vitis vinifera L. (Vitaceae) fruits and has shown prominent protective effects on lung injury, induced by various methods such as LPS (Cao et al., 2011; Jiang et al., 2016) , hypoxia (Özdemir et al., 2014) , sepsis (Kolgazi et al., 2006) , staphylococcal enterotoxin B (Rieder et al., 2012) , nickel (Cao et al., 2020) , methamphetamine (Wang X. et al., ), bleomycin (Şener et al., 2007 , chest trauma (Torun et al., 2017) , and cigarette smoke (Bao et al., 2013) . Wang and coworkers showed that resveratrol ameliorated sepsisinduced lung injury after 30 mg/kg dose of i.p. administration. In their study, the level of Nrf-2, HO-1, p-Akt, IL-10, SOD, and caspase-3 activities as antioxidant and anti-inflammatory markers increased in lung tissue after treatment by resveratrol. Resveratrol was also able to decrease MIP-2, IL-18, and neutrophil leakage in BALF . Flavonoids are another class of polyphenolic compounds whose effects on lung injuries have been extensively studied. Li et al. reported that apigenin C-glycoside, a trihydroxyflavone extracted from Microcos paniculata L. (Malvaceae), showed protective effects against LPS-induced lung injury in BALB/c mice at 20 and 40 mg/kg oral doses. In their study, the inhibition of inflammatory cytokines and NF-κB signaling pathway were found as the main mechanisms of apigenin . Daidzein (2, 4, and 8 mg/kg, i.p.) , an isoflavone widely found in Glycine max (L.) Merr. (soybeans, Fabaceae), and myricetin (10, 20, and 40 mg/kg, i.p.), a hexahydroxyflavone widely found in black tea, inhibited TLR4/MyD88/NF-κB cascade and thereby showed protective effects against LPS-induced lung injury in rats (Feng et al., 2015; Mao and Huang, 2017) . Also, naringenin and its inhalation pharmaceutical dosage form improved the LPSinduced lung injury in rats. This trihydroxyflavanone compound showed protective effects at 100 mg/kg oral administration and 3 mg/rat inhalant administration doses via downregulating the PI3K/Akt and MAPKs pathways Yu et al., 2020) . Besides, anthocyanins such as malvidin derivatives and cyanidin-3-O-glucoside, with similar structures to flavonoids, have also shown protective effects on lung injuries Yan et al., 2015) . Also, wogonin (Yao et al., 2014) , rutin , quercetin , luteolin (Liu B. et al., 2018) , kaempferol , isorhamnetin (Chi et al., 2016) , hyperin (Hu et al., 2019) , hesperetin (Wang N. et al., 2019) , fisetin (Hussain et al., 2019) , breviscapine , eriodictyol , and cardamonin are other flavonoid compounds with protective effects on lung injury through different mechanisms (Table 1) . Besides, such aforementioned flavonoids, as kaempferol (Schwarz et al., 2014) , quercetin , and myricetin (Yu et al., Frontiers in Pharmacology | www.frontiersin.org November 2020 | Volume 11 | Article 588467 2012), in addition to possessing a protective effect on lung injuries, have shown anticoronavirus effects, which increases the importance of their use in the treatment of COVID-19. Phenolic acid derivatives such as curcumin, chlorogenic acid, caffeic acid, salidroside, rosmarinic acid, and apocynin are other compounds with protective effects on lung injury with various mechanisms (Yildiz et al., 2008; Zhang et al., 2010; Chu et al., 2012; Suresh et al., 2012; Xu et al., 2014; Zhang et al., 2014) . Zhang and colleagues showed that curcumin, isolated from Curcuma longa L. (Zingiberaceae), at 200 mg/kg, i.p. dose, protected the LPS-induced lung injury in diabetic rats through suppressing NF-κB pathway . Also, chlorogenic acid (50 mg/kg) and rosmarinic acid (5, 10, and 20 mg/kg), found in many herbs, decreased LPS-induced lung injury complications via inhibiting neutrophils and cells infiltration in BALF and downregulating ERK/MAPK pathway and increasing antioxidant activities Chu et al., 2012) . Salidroside, isolated from Rhodiola rosea L. (Crassulaceae), is another phenolic acid compound that showed the protective effects on lung injury. Salidroside at 10 and 120 mg/kg, i.p., inhibited the expression of proinflammatory cytokines, including IL-6, TNF-α, IL-1β, and transforming growth factor-β1 through suppressing LPS-induced lung injury in mice, and paraquat-induced lung injury in rats, respectively Zhang et al., 2014) . Also, silibinin, as a flavonolignan mixture found in Silybum marianum L, showed a potential effect in blocking STAT pathway and reducing proinflammatory cytokines; thereby it could be a promising agent for the treatment of lung injuries in patients with COVID-19 (Bosch-Barrera et al., 2020) . Silymarin, magnolol, thearubigin, gossypol, tannic acid, chicoric acid, and ellagic acid are other polyphenol compounds with protective effects on lung injury. The mechanisms, main natural source, and other related information are presented in Table 1 . In summary, silymarin, thearubigin, and chicoric acid via upregulating the Nrf2/HO-1 Ding et al., 2019; and magnolol, tannic acid, gossypol, and ellagic acid through downregulating NF-κB pathways improved lung injury (Yunhe et al., 2012; Liu Z. et al., 2013; Guan et al., 2017; Zhang et al., 2019) . In addition, silymarin is an undergoing clinical trial study for the treatment of SARS-CoV-2 lung injury (NCT04394208). In general, due to the anti-inflammatory and antioxidant effects of polyphenol compounds, as well as their antiviral effects (Table 1) , this category of secondary metabolisms of plants has the potential to treat COVID-19 and its complications, including lung injuries. However, the pharmacokinetic parameters of these compounds should be considered . Quinones are another class of phytochemicals with an aromatic ring attached to two carbonyl groups in their structure, including anthraquinones, benzoquinones, naphthoquinones, phenanthrenequinones, and polycyclic quinones derivatives (Figure 3) . Several investigations showed that the quinones derivatives have demonstrated protective effects on lung injury by various mechanisms. Chen and coworkers reported that a phenanthrenequinone isolated from Salvia miltiorrhiza Bunge (Lamiaceae), Tanshinone IIA, suppressed the nucleotide-binding oligomerization domain-like receptors pyrin domain-containing protein 3 (NLRP3), as an inflammatory signaling pathway, at 10 mg/kg i.v. in rats, thereby reducing the oleic acid-induced lung injury . Also, emodin, an anthraquinone found in different laxative plants such as Rheum rhabarbarum L. (Polygonaceae), showed protective effects on LPS-lung injury via activating autophagy pathways at 20 mg/kg i.p. in rats . Shikonin (a naphthoquinone) and thymoquinone (a benzoquinone) are other quinones with protective effects on lung injury (Kanter, 2011; Liang et al., 2013) (Table 1) . Terpenoids are natural carbohydrate compounds, divided into seven categories based on the number of carbons in their structure (Figure 3) , including hemiterpenes (C5), monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), sesterterpenes (C25), triterpenes (C30), and polyterpenes (>C30). These compounds have shown several biological and pharmacological effects, including antioxidant, anticancer and cytotoxic, anti-inflammation, hypoglycemic, antiviral, and analgesic, antimicrobial, and anti-Alzheimer disease effect (Tholl, 2015; Jaeger and Cuny, 2016) . In addition, these compounds have shown protective effects on lung injury with different mechanisms. Eucalyptol, thymol, linalool, eugenol, p-cymene, and geraniol, as monoterpenes isolated from the essential oils of various plants, have improved the lung injuries induced by cigarette smoke and LPS (Table 1 ). In terms of mechanism, these effects are exerted through inhibiting the expression of the anti-inflammatory cytokines and suppressing TLR4/NF-κB and MAPKs pathways, along with decreasing the infiltration of proteins, neutrophils, and cells to BALF. They have also indicated protective effects by reducing the Bax/Bcl-2 ratio and increasing the antioxidant activities (Xie et al., 2012; Huo et al., 2013; Huang et al., 2015; Jiang et al., 2017; Wan et al., 2018; de Lima Gondim et al., 2019) . On the other hand, oridonin, a diterpenoid found in Isodon rubescens (Hemsl.) H.Hara [syn. Rabdosia rubescens (Hemsl.) H.Hara] (Lamiaceae), suppressed the NLRP3 signaling pathway, and NF-κB, as well as activating the Nrf2/HO-1 pathway, and thereby showed protective effects on lung injury at 2.5, 5, and 10 μM in in vitro study and 20 and 40 mg/kg, i.p. in rats (Yang et al., 2019) . Triptolide , isoforskolin , carnosol (Tian et al., 2010) , and andrographolide (Guan et al., 2013) are other diterpenes that are present in various herbal medicines with protective effects on lung injury via activating antioxidant pathways such as Nrf2/HO-1, as well as inhibiting TLR4/NF-κB, proinflammatory cytokines expression, and MAPKs pathways ( Table 1) . Also, sesquiterpenes, such as artemisitene isolated from Artemisia annua L. (Asteraceae) at 10 mg/kg, i.p., in mice , zerumbone, presented in Zingiber zerumbet (L.) Roscoe ex Sm. (Zingiberaceae) at 10 μM/kg, i.p. (Leung et al., 2017) , costunolide, isolated from Lactuca sativa L. (Asteraceae) at 30 mg/kg, i.p., in C57BL/6J mice , and farnesol, isolated from Cymbopogon commutatus (Steud.) Stapf (Poaceae) at 100 mg/kg orally (Qamar and Sultana, 2008) , showed protective effects against lung damage by activating Nrf2/ HO-1 pathway and inhibiting MAPKs pathway and suppressing TNF-α, IL-6, and IL-1β expression. In addition, parthenolide as Tanacetum parthenium sesquiterpene lactones inhibited the cytokine storm in inflammatory conditions. Therefore, it can be a good candidate for clinical trial studies of lung injuries induced by SARS-Cov-2 (Bahrami et al., 2020) . On the other hand, triterpenoids such as rubriflordilactones A, betulinic acid, and taraxasterol also have shown ameliorating effects on lung injuries induced by LPS and sepsis (San et al., 2014; Lingaraju et al., 2015; (Table 1) . Wang and coworkers showed that the rubriflordilactone, isolated from Schisandra sphenanthera Rehder & E.H.Wilson (syn. Schisandra rubriflora Rehder & E.H.Wilson) (Schisandraceae), improved the LPS-lung injury at 10 nM/kg in rats and 10 nM/ml on mouse lung epithelial cell lines (MLE-15) through increasing the expression of sirtuin 1 and suppressing inflammatory markers expression, including MMP9, iNOS, and IL-6 . Saponins are other natural compounds, which are classified in the category of terpenoids. Ginsenoside Rg3 (20 and 30 mg/kg) and Rg1 (40 and 200 mg/kg) are two triterpenes saponins, isolated from Panax ginseng C.A.Mey. (Araliaceae), with improving effects on LPS-lung injury in mice. These compounds inhibited the infiltration of neutrophils and proteins and M2 macrophage in BALFs and reduced pulmonary edema. Their main mechanism of action is through the suppression of NF-κB (Bao et al., 2015; Cheng and Li, 2016) . Increasing the expression of heat shock protein 70 leads to the inhibition of TLR4/MyD88 pathway. The later mechanism is the main protective mechanism of dioscin against lung injury as a steroidal saponin from Dioscorea spp. (Dioscoreaceae) (Zeng et al., 2018) . Soyasaponin , glycyrrhizin (Menegazzi et al., 2008) , and sodium aescinate (Menegazzi et al., 2008) are other saponin compounds with improving effects on lung injury ( Table 1) . Geniposide (20, 40, or 80 mg/Kg, i.p., mice), as an iridoid found in Gardenia jasminoides J.Ellis (Rubiaceae), improved the LPSinduced lung injury via suppressing the NF-κB and MAPKs (Xiaofeng et al., 2012) . Sulforaphane, as an isothiocyanate isolated from Brassica oleracea L. (Brassicaceae), activated the Nrf2 pathway and inhibited the PGE2, COX-2, and MMP-2 at 50 mg/kg, i.p., in BALB/c mice, thereby ameliorating LPS-induced lung injury (Qi et al., 2016) . Consequently, cannabidiol (Figure 3) , as cannabinoid derivative of Cannabis sativa L. (Cannabaceae), and polysaccharides of Houttuynia cordata Thunb. (Saururaceae) showed similar effects through inhibiting the expression of proinflammatory cytokines (TNF-α and IL-6) and reducing the infiltration of cells and proteins in BALF (Ribeiro et al., 2015; Xu et al., 2015) . Also, cannabidiol inhibited the cytokines storminduced by viral infection at 5 mg/kg in C57BL/6 mice (Khodadadi et al., 2020) . Besides, a clinical trial is underway on cannabidiol and its derivatives for the treatment of lung injury in patients with . In general, due to the protective effects of the aforementioned phytochemicals on lung injuries, these compounds can be used as a protector and treatment in lung injuries leftover from coronavirus activity, including COVID-19. Given the antiviral effects (especially anticoronavirus) of some of the compounds listed in Table 1 , this role could lead researchers to find much more effective multitarget compounds in the treatment of patients with COVID-19 and its complications. Since the World Health Organization (WHO) announced the pandemic of COVID-19 disease (March 11, 2020) , no effective treatment or vaccine has been introduced to treat this disease. Besides, to eliminate the SARS-CoV-2, conventional medications have either failed or been used taking them in doses higher than their therapeutic index leading to side effects (Ianevski et al., 2020; . On the other hand, due to their multitarget character, phytochemicals have always been of the options for discovering drug molecules to treat complicated diseases, including viral diseases and their complications. On the other hand, lung injury is the main COVID-19 complication that happens with inflammatory cascades by SARS-CoV-2 (Fakhri et al., 2020b; Merad and Martin, 2020) . In the present review, we described the candidate phytochemicals with protective effects on lung injuries induced by various methods, as well as their pharmacological mechanisms (Figure 4 ). In addition, we showed some phytochemicals possessing protective effects against lung injury, with a focus on cepharanthine, epigoitrin, isofraxidin, osthole, resveratrol, apigenin, kaempferol, myricetin, quercetin, chlorogenic acid, chicoric acid, emodin, thymoquinone, betulinic acid, eucalyptol, oridonin, zerumbone, glycyrrhizin, and sulforaphane and their antiviral activities ( Table 1) . On the other hand, despite the effectiveness of natural secondary metabolites in combating viral diseases, providing the novel drug delivery systems helps to drawback their pharmacokinetic limitations (Abbaszadeh et al., 2020; Fakhri et al., 2020a) . Such reports could pave the way for discovering alternative drugs with anti-CoV effects and the potential in controlling the complication of COVID-19. Additional studies are needed to reveal the precise dysregulated pathways in COVID-19 and clarify the potential effects of phytochemicals on humans. MM and MF contributed to conceptualization; MM, SF, and MF contributed to designing the structure of the paper; MM and SF contributed to software; MM, SF, YS, NK, KS, PM, MG, MF, and JE contributed to drafting the manuscript; and MM, SF, MF, and JE contributed to reviewing and editing the paper. JE gratefully acknowledges funding from CONICYT (PAI/ ACADEMIA No. 79160109). Targeting apoptosis and autophagy following spinal cord injury: therapeutic approaches to polyphenols and candidate phytochemicals Betulinic acid derivatives as HIV-1 antivirals Glycyrrhizin as antiviral agent against hepatitis C virus Cytokine storm in COVID-19 and parthenolide: preclinical evidence Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice Glycyrrhizin: an alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Coumarin: a potential nucleus for antiinflammatory molecules Apple polyphenol protects against cigarette smoke-induced acute lung injury Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages Phytochemicals to prevent inflammation and allergy. Recent Pat. Inflamm Emetine, ipecac, ipecac alkaloids and analogues as potential antiviral agents for coronaviruses Silibinin and SARS-CoV-2: dual targeting of host cytokine storm and virus replication machinery for clinical management of COVID-19 patients Protective effect of resveratrol on acute lung injury induced by lipopolysaccharide in mice Resveratrol protects human bronchial epithelial cells against nickel-induced toxicity via suppressing p38 MAPK, NF-κB signaling, and NLRP3 inflammasome activation Anti-HIV activity of natural triterpenoids and hemisynthetic derivatives 2004-2009 Anti-human coronavirus (anti-HCoV) triterpenoids from the leaves of Euphorbia neriifolia Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells Tanshinone ⅡA ameliorates acute lung injury by inhibition of the NLRP3 inflammasome Artemisitene activates the Nrf2-dependent antioxidant response and protects against bleomycininduced lung injury Protective effect of rutin on LPS-induced acute lung injury via downregulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice Costunolide alleviates HKSA-induced acute lung injury via inhibition of macrophage activation Antiviral effects of saikosaponins on human coronavirus 229E in vitro Beneficial effect of the polysaccharides from Bupleurum smithii var. parvifolium on "two-hit" acute lung injury in rats Ginsenoside Rg3 ameliorates lipopolysaccharideinduced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis Antiviral constituents from Vicoa indica Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Potential effects of medicinal plants and secondary metabolites on acute lung injury Zerumbone, an HIV-inhibitory and cytotoxic sesquiterpene of Zingiber aromaticum and Z. zerumbet Antiviral effect of methylated flavonol isorhamnetin against influenza Effects of Eucalyptol in respiratory system mechanics on acute lung injury after exposure to short-term cigarette smoke Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/ Akt pathways Chicoric acid alleviates lipopolysaccharide-induced acute lung injury in mice through antiinflammatory and anti-oxidant activities The clinical pathology of severe acute respiratory syndrome (SARS): a report from Emodin reactivated autophagy and alleviated inflammatory lung injury in mice with lethal endotoxemia The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism Astaxanthin, COVID-19 and immune response: focus on oxidative stress, apoptosis and autophagy Daidzein attenuates lipopolysaccharideinduced acute lung injury via toll-like receptor 4/NF-kappaB pathway Synthesis of thymoquinone-artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents Antiinflammatory and anti-apoptotic effects of oxysophoridine on lipopolysaccharide-induced acute lung injury in mice A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities Antiviral activity of some hydroxycoumarin derivatives Angiotensinconverting enzyme 2 inhibits lung injury induced by respiratory syncytial virus Multiple organ infection and the pathogenesis of SARS Pathology and pathogenesis of severe acute respiratory syndrome Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice Ellagic acid protects against LPS-induced acute lung injury through inhibition of nuclear factor kappa B, proinflammatory cytokines and enhancement of interleukin-10 Anti-hepatitis B virus activity of wogonin in vitro and in vivo Dietary polyphenols, inflammation, and cancer Oridonin suppresses transplant rejection by depleting T cells from the periphery Broad-spectrum antiviral properties of andrographolide Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Inhibitory activity of soyasaponin II on virus replication in vitro The protective effect of hyperin on LPS-induced acute lung injury in mice Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264. 7 cell and mouse models Anti-inflammatory effects of eugenol on lipopolysaccharide-induced inflammatory reaction in acute lung injury via regulating inflammation and redox status Antiinflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model The plant flavonoid, fisetin alleviates cigarette smokeinduced oxidative stress, and inflammation in Wistar rat lungs Potential antiviral options against SARS-CoV-2 infection Terpenoids with special pharmacological significance: a review Geraniol alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation Isofraxidin ameliorated influenza viral inflammation in rodents via inhibiting platelet aggregation Osthole protects against acute lung injury by suppressing NF-κB-dependent inflammation Inhibition of SARS-CoV 3CL protease by flavonoids Thymoquinone attenuates lung injury induced by chronic toluene exposure in rats Therapeutic potential of gossypol: an overview Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling Cannabidiol modulates cytokine storm in acute respiratory distress syndrome induced by simulated viral infection using synthetic RNA Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia Resveratrol reduces renal and lung injury caused by sepsis in rats Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges Esculetin ameliorates lipopolysaccharide-induced acute lung injury in mice via modulation of the AKT/ERK/NF-κB and RORγt/IL-17 pathways Antiviral activity of some flavonoids on herpes simplex viruses Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Protective effect of zerumbone reduces lipopolysaccharide-induced acute lung injury via antioxidative enzymes and Nrf2/HO-1 pathway Sinomenine protects against lipopolysaccharide-induced acute lung injury in mice via adenosine A2A receptor signaling Apigenin C-glycosides of Microcos paniculLeung et al., 2020Leung et al., 2020ata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway. Free Radic Identification of natural compounds with antiviral activities against SARSassociated coronavirus Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways Synergistic protection of matrine and lycopene against lipopolysaccharideinduced acute lung injury in mice Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway Isotetrandrine protects against lipopolysaccharide-induced acute lung injury by suppression of mitogen-activated protein kinase and nuclear factor-kappa B Berberine ameliorates lipopolysaccharide-induced acute lung injury via the PERKmediated Nrf2/HO-1 signaling axis Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plantderived phenolic compounds Soyasaponin Ab inhibits lipopolysaccharide-induced acute lung injury in mice Effective inhibition of MERS-CoV infection by resveratrol Fisetin and rutin as 3C protease inhibitors of enterovirus A71 Chicoric acid analogues as HIV-1 integrase inhibitors Betulinic acid negates oxidative lung injury in surgical sepsis model Protective effects of dietary luteolin against mercuric chloride-induced lung injury in mice: involvement of AKT/Nrf2 and NF-κB pathways Dioscin's antiviral effect in vitro Sinomenine protects against E. coli-induced acute lung injury in mice through Nrf2-NF-κB pathway Isosteroid alkaloids from Fritillaria cirrhosa bulbus as inhibitors of cigarette smoke-induced oxidative stress Blueberry anthocyanins ameliorate radiation-induced lung injury through the protein kinase RNA-activated pathway Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice Potential of cannabidiol for the treatment of viral hepatitis Antidesmone, a unique tetrahydroquinoline alkaloid, prevents acute lung injury via regulating MAPK and NF-κB activities Protective effect of sophocarpine on lipopolysaccharide-induced acute lung injury in mice The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase Epigoitrin, an alkaloid from Isatis indigotica, reduces H1N1 infection in stress-induced susceptible model in vivo and in vitro Isofraxidin: synthesis, biosynthesis, isolation, Frontiers in Pharmacology | www Natural product-derived phytochemicals as potential agents against coronaviruses: a review Myricetin attenuates lung inflammation and provides protection against lipopolysaccharide-induced acute lung injury by inhibition of NF-κB pathway in rats Management of COVID-19 respiratory distress Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages Osthole prevents intestinal ischemia-reperfusion-induced lung injury in a rodent model Effective antiviral activity of essential oils and their characteristic terpenes against coronaviruses: an update Protective effects of scoparone against lipopolysaccharide-induced acute lung injury Protective effects of isofraxidin against lipopolysaccharide-induced acute lung injury in mice Biological effects of myricetin Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids The effects of resveratrol on hyperoxia-induced lung injury in neonatal rats The effects of bosentan on hyperoxia-induced lung injury in neonatal rats Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses Rosmarinic acid Plant polyphenols: structure, occurrence and bioactivity The signaling pathways, and therapeutic targets of antiviral agents: focusing on the antiviral approaches and clinical perspectives of anthocyanins in the management of viral diseases Eugenol: a natural compound with versatile pharmacological actions Farnesol ameliorates massive inflammation, oxidative stress and lung injury induced by intratracheal instillation of cigarette smoke extract in rats: an initial step in lung chemoprevention Sulforaphane exerts antiinflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A2A receptor Tendências evolutivas de famílias produtoras de cumarinas em angiospermae Outcomes in patients with COVID-19 infection taking ACEI/ARB Multiple anti-inflammatory pathways triggered by resveratrol lead to amelioration of staphylococcal enterotoxin B-induced lung injury Investigation of anticancer and antiviral properties of selected aroma samples Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice Polyphenols, intracellular signalling and inflammation Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus Emodin inhibits current through SARS-associated coronavirus 3a protein The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells Resveratrol alleviates bleomycin-induced lung injury in rats Comparison of the antiviral activity of flavonoids against murine norovirus and feline calicivirus Susceptibility ofherpes simplex virus type 1 to monoterpenes thymol, carvacrol, p-cymene and essential oils of Sinapis arvensis L., Lallemantia Frontiers in Pharmacology | www Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatments strategies Eucalyptol (1,8-cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by molecular docking studies Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264. 7 cells via suppressing JAK/STATs activation and ROS production Osthole protects lipopolysaccharide-induced acute lung injury in mice by preventing down-regulation of angiotensin-converting enzyme 2 The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels Antiviral and cytotoxic evaluation of coumarins from Prangos ferulacea Mechanistic evidence to support the anti-hepatitis B viral activity of multifunctional scaffold & conformationally restricted magnolol Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury Antiviral activity of ginsenosides against coxsackievirus B3, enterovirus 71, and human rhinovirus 3 Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic Grape extract, resveratrol, and its analogs: a review A review on pharmacological properties of coumarins Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats Autophagy involved in antiviral activity of sodium tanshinone IIA sulfonate against porcine reproductive and respiratory syndrome virus infection in vitro Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury Biosynthesis and biological functions of terpenoids in plants Protective effect of carnosol on lung injury induced by intestinal ischemia/reperfusion A study of the therapeutic effects of resveratrol on blunt chest trauma-induced acute lung injury in rats and the potential role of endocan as a biomarker of inflammation Resveratrol suppresses neutrophil activation via inhibition of Src family kinases to attenuate lung injury. Free Radic Osthol attenuates neutrophilic oxidative stress and hemorrhagic shock-induced lung injury via inhibition of phosphodiesterase 4. Free Radic Review on natural coumarin lead compounds for their pharmacological activity Stilbene-based natural compounds as promising drug candidates against COVID-19 Preventive and therapeutic effects of thymol in a lipopolysaccharide-induced acute lung injury mice model Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Umbelliferone alleviates lipopolysaccharide-induced inflammatory responses in acute lung injury by down-regulating TLR4/MyD88/NF-κB signaling The total alkaloid fraction of bulbs of Fritillaria cirrhosa displays anti-inflammatory activity and attenuates acute lung injury The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3 Preventive and therapeutic effects of quercetin on experimental radiation induced lung injury in mice. Asian Pac Hesperetin ameliorates lipopolysaccharide-induced acute lung injury in mice through regulating the TLR4-MyD88-NF-κB signaling pathway Sinomenine attenuates septic-associated lung injury through the Nrf2-Keap1 and autophagy Thearubigin regulates the production of Nrf2 and alleviates LPS-induced acute lung injury in neonatal rats Resveratrol protects the integrity of alveolar epithelial barrier via SIRT1/PTEN/p-Akt pathway in methamphetamine-induced chronic lung injury Antiinflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of ICAM-1 and IL-18 Alleviation of acute lung injury in rats with sepsis by resveratrol via the phosphatidylinositol 3-kinase/ nuclear factor-erythroid 2 related factor 2/heme oxygenase-1 (PI3K/Nrf2/HO-1) pathway Frontiers in Pharmacology | www.frontiersin.org Inhibition of acute lung injury by rubriflordilactone in LPS-induced rat model through suppression of inflammatory factor expression Cardamonin protects septic mice from acute lung injury by preventing endothelial barrier dysfunction Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19 In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik Geniposide, an iridoid glucoside derived from Gardenia jasminoides, protects against lipopolysaccharide-induced acute lung injury in mice p-Cymene protects mice against lipopolysaccharide-induced acute lung injury by inhibiting inflammatory cell activation Protective effects of apocynin nitrone on acute lung injury induced by lipopolysaccharide in rats Houttuynia cordata Thunb. polysaccharides ameliorates lipopolysaccharideinduced acute lung injury in mice Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression Cyanidin-3-Oglucoside attenuates acute lung injury in sepsis rats Antiinfluenza activity of berberine improves prognosis by reducing viral replication in mice Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways Psoralidin, a dual inhibitor of COX-2 and 5-LOX, regulates ionizing radiation (IR)-induced pulmonary inflammation TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury Trends for diverse production strategies of plant medicinal alkaloids Resveratrol alleviates sepsis-induced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells Isoforskolin pretreatment attenuates lipopolysaccharide-induced acute lung injury in animal models Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective Antiviral effect of matrine against human enterovirus 71 Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway. Free Radic Protective effects of caffeic acid phenethyl ester on radiation induced lung injury in rats MERS, SARS and other coronaviruses as causes of pneumonia Sulforaphane suppresses hepatitis C virus replication by up-regulating heme oxygenase-1 expression through PI3K/Nrf2 pathway Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13 /hydrochloric acid induced acute lung injury in mice Antiinflammatory and protective properties of daphnetin in endotoxin-induced lung injury Naringenin-Loaded dipalmitoylphosphatidylcholine phytosome dry powders for inhaled treatment of acute lung injury The effect of magnolol on the toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice Dioscin prevents LPSinduced acute lung injury through inhibiting the TLR4/MyD88 signaling pathway via upregulation of HSP70 Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus Curcumin alleviates lung injury in diabetic rats by inhibiting nuclear factor-κB pathway Ameliorative effects of tannic acid on lipopolysaccharide-induced sepsis and acute lung injury in mice Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury Antiviral activity of a synthesized shikonin ester against influenza a (H1N1) virus and insights Frontiers in Pharmacology | www Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo SARS-CoV-2) in cell culture Salidroside alleviates paraquat-induced rat acute lung injury by repressing TGF-β1 expression Silymarin attenuates paraquatinduced lung injury via Nrf2-mediated pathway in vivo and in vitro Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis Naringenin ameliorates LPS-induced acute lung injury through its anti-oxidative and antiinflammatory activity and by inhibition of the PI3K/AKT pathway Eriodictyol, a plant flavonoid, attenuates LPS-induced acute lung injury through its antioxidative and anti-inflammatory activity Protective effects of resveratrol on hyperoxia-induced lung injury in neonatal rats by alleviating apoptosis and ROS production ACE2: its potential role and regulation in severe acute respiratory syndrome and COVID-19 A review on antibacterial, antiviral, and antifungal activity of curcumin The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2020 Majnooni, Fakhri, Shokoohinia, Kiyani, Stage, Mohammadi, Gravand, Farzaei and Echeverria. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.